Skip to main content
SpringerLink
Log in

Growth in precocious puberty

  • Symposium on Growth and Its Disorders — II
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Growth in precocious puberty is a subject of concern to families and clinicians alike. The definition of precocious puberty and the role of obesity in the age of onset have also been areas of debate since the Lawson Wilkins Society recommended a lowering of the age of onset of precocious puberty in US girls. An understanding of growth patterns in normal children with earlier or later onset of puberty and the variable rate of progression between individuals with central precocious puberty as well as the imprecision in available height prediction methods are important in assessing height outcomes in this condition. In the absence of randomised controlled trials in this area, only qualified conclusions about the effectiveness of interventions can be drawn. In general, it appears that height outcome is not compromised in untreated slowly progressive variants of central precocious puberty. In rapidly progressing central precocious puberty in girls, gonadotrophin releasing hormone agonists (GnRH agonists) appear to increase final height by about 5cm in girls treated before the age of eight, but there is no height benefit in those treated after eight years. Scanly data is available to assess treatment effects in boys. GnRH agonists appear to be relatively safe. The decision to treat central precocious puberty should take into account rate of progression of pubertal changes as well as biochemical markers and may need to address other factors (for example psychosocial and behavioural issues) as well as height outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls.Arch Dis Child 1969; 44(235): 291–303.

    PubMed  CAS  Google Scholar 

  2. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys.Arch Dis Child 1970; 45(239): 13–23.

    PubMed  CAS  Google Scholar 

  3. Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, Hasemeier CM. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network.Pediatrics 1997; 99(4): 505–512.

    Article  PubMed  CAS  Google Scholar 

  4. Kaplowitz PB and Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society.Pediatrics 1999; 104(4 Pt 1): 936–941.

    Article  PubMed  CAS  Google Scholar 

  5. Klein KO. Precocious puberty: who has it? Who should be treated?.J Clin Endocrinol Metab 1999; 84(2): 411–414.

    Article  PubMed  CAS  Google Scholar 

  6. Mul D, Fredriks AM, van Buuren S, Oostdijk W, Verloove-Vanhorick SP, Wit JM. Pubertal development in The Netherlands 1965–1997.Pediatr. Res 2001; 50(4): 479–486.

    Article  PubMed  CAS  Google Scholar 

  7. Midyett LK, Moore WV, Jacobson JD. Are pubertal changes in girls before age 8 benign?Pediatrics 2003; 111(1): 47–51.

    Article  PubMed  Google Scholar 

  8. Lindgren G. Pubertal stages 1980 of Stockholm schoolchildren.Acta Paediatr 1996; 85(11): 1365–1367.

    PubMed  CAS  Google Scholar 

  9. Huen KF, Leung SS, Lau JT, Cheung AY, Leung NK, Chiu MC. Secular trend in the sexual maturation of southern Chinese girls.Acta Paediatr 1997; 86(10): 1121–1124.

    PubMed  CAS  Google Scholar 

  10. Thomas F, Renaud F, Benefice E, de Meeus T, Guegan JF. International variability of ages at menarche and menopause: patterns and main determinants.Hum Biol 2001; 73: 271–290.

    Article  PubMed  CAS  Google Scholar 

  11. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration.Endocr Rev 2003; 24(5): 668–693.

    Article  PubMed  Google Scholar 

  12. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys and girls.Pediatrics 2002; 110: 903–909.

    Article  PubMed  Google Scholar 

  13. Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race.Pediatrics 2001; 108(2): 347–353.

    Article  PubMed  CAS  Google Scholar 

  14. Kappy MS, Ganong CS. Advances in the treatment of precocious puberty.Adv Pediatr 1994; 41: 223–261.

    PubMed  CAS  Google Scholar 

  15. Cisternino M, Arrigo T, Pasquino AM, Tinelli C, Antoniazzi F, Beduschi L, Bindi G, Borrelli P, De Sanctis V, Farello G, Galluzzi F, Gargantini L, Lo Presti D, Sposito M, Tato L. Etiology and age incidence of precocious puberty in girls: a multicentric study.J Pediatr Endocrinol Metab 2000; 13 Suppl 1: 695–701.

    PubMed  Google Scholar 

  16. De Sanctis V, Corrias A, Rizzo V, Bertelloni S, Urso L, Galluzzi F, Pasquino AM, Pozzan G, Guarneri MP, cisternino M, De Luca F, Gargantini L, Pilotta A, Sposito M, Tonini G. Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty.J Pediatr Endocrinol Metab 2000; 13 Suppl 1: 687–693.

    PubMed  Google Scholar 

  17. Pescovitz OH, Comite F, Hench K, Barnes K, McNemar A, Foster C, Kenigsberg D, Loriaux DL, Cutler GB Jr. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.J Pediatr 1986; 108(1): 47–54.

    Article  PubMed  CAS  Google Scholar 

  18. Thamdrup E. 1961. Precocious sexual development. A clinical study of 100 children. Copenhagen; Munksgaard, 104–105.

    Google Scholar 

  19. Grunt JA, Midyett LK, Simon SD, Lowe L. When should cranial magnetic resonance imaging be used in girls with early sexual development?J Pediatr Endocrinol Metab 2004; 17(5): 775–780.

    PubMed  Google Scholar 

  20. Anasti JN, Flack MR, Froeloich Jet al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism.J Clin Endocrinol Metab 1995; 80: 276–279.

    Article  PubMed  CAS  Google Scholar 

  21. Van Wyk JJ, Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: An example of hormonal overlap in pituitary feedback.J Pediatr 1960; 57: 416–435.

    Article  Google Scholar 

  22. Chattopadhyay A, Kumar V, Marulaiah M. Polycystic ovaries, precocious puberty and acquired hypothyroidism: The Van Wyk and Grumbach syndrome.J Pediatr Surg 2003; 38(9): 1390–1392.

    Article  PubMed  Google Scholar 

  23. Bourguignon JP, Gerard A, Alvarez Gonzalez ML, Fawe L, Franchimont P. Effects of changes in nutritional conditions on timing of puberty: clinical evidence from adopted children and experimental studies in the male rat.Horm Res 1992; 38 Suppl 1:97–105.

    PubMed  Google Scholar 

  24. Adolfson S, Westphal O. Early pubertal development in girls adopted from Far Eastern countries.Pediatr Res 1981; 15; 82 (abstract).

    Article  Google Scholar 

  25. Bajpai A, Sharma J, Kabra M, Kumar Gupta A, Menon PS. Precocious puberty: clinical and endocrine profile and factors indicating neurogenic precocity in Indian children.J Pediatr Endocrinol Metab 2002; 15(8): 1173–1181.

    PubMed  Google Scholar 

  26. Carel JC, Chaussain JL. Gonadotropin releasing hormone agonist treatment for central precocious puberty.Horm Res 1999; 51 Suppl 3:64–9.

    Article  PubMed  CAS  Google Scholar 

  27. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB Jr. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.J Clin Endocrinol Metab 1988; 67(3): 474–479.

    PubMed  CAS  Google Scholar 

  28. Neely EK, Hintz RL, Wilson DM, Lee PA, Gautier T, Argente J, Stene M. Normal ranges for immunochemiluminometric gonadotropin assays.J Pediatr 1995; 127(1): 40–46.

    Article  PubMed  CAS  Google Scholar 

  29. Kaplan SL, Grumbach MM. Clinical review 14: Pathophysiology and treatment of sexual precocity.J Clin Endocrinol Metab 1990; 71(4): 785–789.

    PubMed  CAS  Google Scholar 

  30. Leger J, Reynaud R, Czernichow P. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?J Pediatr 2000; 137(6): 819–825.

    Article  PubMed  CAS  Google Scholar 

  31. Rosenfield RL. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs.J Pediatr 1994; 124(6): 989–991.

    Article  PubMed  CAS  Google Scholar 

  32. Kvale G, Heuch I. Menstrual factors and breast cancer risk.Cancer 1988; 62(8): 1625–1631.

    Article  PubMed  CAS  Google Scholar 

  33. Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, Sellers TA, Kushi LH, Ruan Z, Bostick RM, Jin F, Zheng W. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer.Study Int J Cancer 2000; 87(2): 295–300.

    Article  CAS  Google Scholar 

  34. Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women.N Engl J Med 2004; 351(16): 1619–1626.

    Article  PubMed  CAS  Google Scholar 

  35. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards.J Pediatr 1952; 40(4): 423–441.

    Article  PubMed  CAS  Google Scholar 

  36. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Corrias A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi Set al. Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments.Acta Paediatr 1994; 83(10): 1052–1056.

    PubMed  CAS  Google Scholar 

  37. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.Horm Res 1997; 47(2): 54–61.

    Article  PubMed  CAS  Google Scholar 

  38. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with centralpprecocious puberty: correlation with adult height.J Pediatr 1995; 126(6): 955–958.

    Article  PubMed  CAS  Google Scholar 

  39. Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.J Clin Endocrinol Metab 2001; 86(9): 4127–4132.

    Article  PubMed  CAS  Google Scholar 

  40. Kelnar CJ, Stanhope R. Height prognosis in girls with central precocious puberty treated with GnRH analogues. [Commentary].Clin Endo (Oxf) 2002; 56: 295–296.

    Article  CAS  Google Scholar 

  41. Coste J, Ecosse E, Lesage C, Chaussain JL, Carel JC. Evaluation of adolescent statural growth in health and disease: reliability of assessment from height measurement series and development of an automated algorithm.Horm Res 2002; 58(3): 105–114.

    Article  PubMed  CAS  Google Scholar 

  42. Vizmanos B, Marti-Henneberg C, Cliville R, Moreno A, Fernandez-Ballart J. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height.Am J Hum Biol 2001; 13(3): 409–416.

    Article  PubMed  CAS  Google Scholar 

  43. Biro FM, McMahon RP, Striegel-Moore R, Crawford PB, Obarzanek E, Morrison JA, Barton BA, Falkner F. Impact of timing of pubertal maturation on growth in black and white female adolescents: The National Heart, Lung, and Blood Institute Growth and Health Study.J Pediatr 2001; 138(5): 636–643.

    Article  PubMed  CAS  Google Scholar 

  44. Fontoura M, Brauner R, Prevot C, Rappaport R. Precocious puberty in girls: early diagnosis of a slowly progressing variant.Arch Dis Child 1989; 64(8): 1170–1176.

    PubMed  CAS  Google Scholar 

  45. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients.J Clin Endocrinol Metab 1999; 84(2): 415–423.

    Article  PubMed  CAS  Google Scholar 

  46. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, Waelkens JJ, Drop SL. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience.J Pediatr Endocrinol Metab 2000; 13 Suppl 1: 765–772.

    PubMed  Google Scholar 

  47. Pucarelli I, Segni M, Ortore M, Arcadi E, Pasquino AM. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution.J Pediatr Endocrinol Metab 2003; 16(7): 1005–1010.

    PubMed  CAS  Google Scholar 

  48. Sorgo W, Kiraly E, Homoki J, Heinze E, Teller WM, Bierich JR, Moeller H, Ranke MB, Butenandt O, Knorr D. The effects of cyproterone acttate on statural growth in children with precocious puberty.Acta Endocrinol (Copenh) 1987; 115(1): 44–56.

    CAS  Google Scholar 

  49. Beyer J, Demisch K, Wiegelmann W, Happ J, Kollmann F, Schoffling K. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty.Acta Endocrinol Suppl (Copenh) 1973; 173: 169.

    CAS  Google Scholar 

  50. Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL.et al. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.J Clin Endocrinol Metab 1984; 58(5): 857–861.

    Article  PubMed  CAS  Google Scholar 

  51. Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue.Ann N Y Acad Sci 1993; 687:250–254.

    Article  PubMed  CAS  Google Scholar 

  52. Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog.Metabolism 1997; 46(5): 513–517.

    Article  PubMed  CAS  Google Scholar 

  53. Quintos JB, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.J Clin Endocrinol Metab 2001; 86(4): 1511–1517.

    Article  PubMed  CAS  Google Scholar 

  54. Palmert MR, Mansfield MJ, Crowley WF Jr, Crigler JF Jr, Crawford JD, Boepple PA. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.J Clin Endocrinol Metab 1999; 84(12): 4480–4488.

    Article  PubMed  CAS  Google Scholar 

  55. Heger S, Partsch CJ, Sippell WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.J Clin Endocrinol Metab 1999; 84(12): 4583–4590. [Erratum in:J Clin Endocrinol Metab 2000; 85(2): 657.]

    Article  PubMed  CAS  Google Scholar 

  56. Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.Eur J Pediatr 1998; 157(5): 363–367.

    Article  PubMed  CAS  Google Scholar 

  57. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, Tato L. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.J Clin Endocrinol Metab 2003; 88(3): 1096–1101.

    Article  PubMed  CAS  Google Scholar 

  58. Sigurjonsdottir TJ, Hayles AB. Precocious puberty. A report of 96 cases.Am J Dis Child 1968; 115(3): 309–321.

    PubMed  CAS  Google Scholar 

  59. Bovier-Lapierre M, Sempe M, David M. [Etiological, clinical and biological aspects of precocious puberty of central origin].Pediatrie 1972; 27(6): 587–609. [Article in French]

    PubMed  CAS  Google Scholar 

  60. Werder EA, Murset G, Zachmann M, Brook CG, Prader A. Treatment of precocious puberty with cyproterone acetate.Pediatr Res 1974; 8(4): 248–256.

    Article  PubMed  CAS  Google Scholar 

  61. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls.Am J Dis Child 1981; 135(5): 443–445.

    PubMed  CAS  Google Scholar 

  62. Schoevaart CE, Drop SL, Otten BJ, Slijper FM, Degenhart HJ. Growth analysis up to final height and psychosocial adjustment of treated and untreated patients with precocious puberty.Horm Res 1990; 34(4–6): 197–203.

    PubMed  CAS  Google Scholar 

  63. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years.J Clin Endocrinol Metab 1995; 80(2): 546–551.

    Article  PubMed  CAS  Google Scholar 

  64. Kauli R, Kornreich L, Laron Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy.Horm Res 1990; 33(1): 11–17.

    PubMed  CAS  Google Scholar 

  65. Brauner R, Adan L, Malandry F, Zantleifer D. Adult height in girls with idiopathic true precocious puberty.J Clin Endocrinol Metab 1994; 79(2): 415–420.

    Article  PubMed  CAS  Google Scholar 

  66. Oostdijk W, Rikken B, Schreuder S, Otten B, Odink R, Rouwe C, Jansen M, Gerver WJ, Waelkens J, Drop S. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist.Arch Dis Child 1996; 75(4): 292–297.

    PubMed  CAS  Google Scholar 

  67. Galluzzi F, Salti R, Bindi G, Pasquini E, La Cauza C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy.Acta Paediatr 1998; 87(5): 521–527.

    Article  PubMed  CAS  Google Scholar 

  68. Arrigo T, Cisternino M, Galluzzi F, Bertelloni S, Pasquino AM, Antoniazzi F, Borrelli P, Crisafulli G, Wasniewska M, De Luca F. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty.Eur J Endocrinol 1999; 141(2): 140–144.

    Article  PubMed  CAS  Google Scholar 

  69. Cassio A, Cacciari E, Balsamo A, Bal M, Tassinari D. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5–8.5 years.Arch Dis Child 1999; 81(4): 329–332.

    PubMed  CAS  Google Scholar 

  70. Klein KO, Barnes KM, Jones JV, Feuillan PP, Cutler GB Jr. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.J Clin Endocrinol Metab 2001; 86(10): 4711–4716.

    Article  PubMed  CAS  Google Scholar 

  71. Adan L, Chemaitilly W, Trivin C, Brauner R. Factors predicting adult height in girls with idiopathic central precocious puberty: implications for treatment.Clin Endocrinol (Oxf) 2002; 56(3): 297–302.

    Article  CAS  Google Scholar 

  72. Mul D, Bertelloni S, Carel JC, Saggese G, Chaussain JL, Oostdijk W. Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: final height results.Horm Res 2002; 58(1): 1–7.

    Article  PubMed  CAS  Google Scholar 

  73. Rizzo V, De Sanctis V, Corrias A, Fortini M, Galluzzi F, Bertelloni S, Guarneri MP, Pozzan G, Cisternino M, Pasquino AM. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with ganadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty.J Pediatr Endocrinol Metab 2000; 13 Suppl 1: 781–786.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology and Diabetes, Royal Children's Hospital, Flemington Road, 3052, Parkville, Victoria, Australia

    Justin J. Brown & Garry L. Warne (Professor Garry Warne)

  2. Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia

    Justin J. Brown & Garry L. Warne (Professor Garry Warne)

  3. Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia

    Garry L. Warne (Professor Garry Warne)

Authors
  1. Justin J. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garry L. Warne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Garry L. Warne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, J.J., Warne, G.L. Growth in precocious puberty. Indian J Pediatr 73, 81–88 (2006). https://doi.org/10.1007/BF02758267

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02758267

Key words

Search

Navigation